Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study

  • 234 Accesses

  • 4 Citations



Oxidative stress is accepted as a non-classical cardiovascular risk factor in patients on maintenance hemodialysis (HD). The aim of this study was to evaluate the impact of cinacalcet on oxidative stress biomarkers, oxidative DNA damage (8-hydroxy-2′-deoxyguanosine/deoxyguanosine), endothelial function (FMD %) and carotid artery intima-media thickness (CIMT) in HD patients.


Forty-two chronic HD patients with secondary hyperparathyroidism undergoing 60 mg/day cinacalcet treatment with a follow-up of 6 months and 38 age- and sex-matched healthy individuals were included in this prospective study. Plasma malondialdehyde (MDA) levels and 8-hydroxy-2′-deoxyguanosine/deoxyguanosine ratio (8-OHdG/dG) were determined as oxidative stress markers. Superoxide dismutase (SOD), paraoxonase (PON), catalase (CAT), carbonic anhydrase (CAN) and glutathione peroxidase (GPx) activities were measured as antioxidants. FMD % and CIMT were assessed by ultrasonography.


MDA levels were decreased; SOD, PON, CAT, CAN and GPx activities were increased after 6 months of cinacalcet treatment in HD patients. Although CIMT remained stabile, there was a significant improvement in FMD % as well as a notable reduction trend in 8-OHdG/dG ratio after 6 months of treatment.


Our data have demonstrated that cinacalcet improves oxidative stress, genomic damage, endothelial function and increases antioxidant protection in HD patients after 6 months of treatment.

This is a preview of subscription content, log in to check access.


  1. 1.

    Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D (2000) Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant 15:69–80

  2. 2.

    Ma KW, Grene EL, Raij L (1992) Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 19:505–513

  3. 3.

    Fujisawa M, Haramaki R, Miyazaki H, Imaizumi T, Okuda S (2000) Role of lipoprotein (a) and TGF-beta 1 in atherosclerosis of hemodialysis patients. J Am Soc Nephrol 11:1889–1895

  4. 4.

    Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen YA, Yakupoglu G, Ersoy FF, Tuncer M (2009) Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton) 14(3):273–280

  5. 5.

    Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T (2008) Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis. Nephrol Dial Transplant 23(5):1697–1703

  6. 6.

    Vita JA, Keaney JF Jr, Raby KE, Morrow JD, Freedman JE, Lynch S, Koulouris SN, Hankin BR, Frei B (1998) Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 31(5):980–986

  7. 7.

    Nyyssönen K, Porkkala-Sarataho E, Kaikkonen J, Salonen JT (1997) Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in finnish men. Atherosclerosis 130(1–2):223–233

  8. 8.

    Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98(15):1487–1494

  9. 9.

    Yildiz A, Gür M, Yilmaz R, Demirbağ R, Celik H, Aslan M, Koçyiğit A (2008) Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension. Turk Kardiyol Dern Ars 36(4):231–238

  10. 10.

    De Francisco AL, Pinera C, Palomar R, Arias M (2006) Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization. J Am Soc Nephrol 17(Suppl):281–285

  11. 11.

    McCullough PA, Soman S (2004) Cardiovascular calcification in patients with chronic renal failure: are we on target with this risk factor? Kidney Int 90(Suppl):18–24

  12. 12.

    Balci M, Kirkpantur A, Gulbay M, Gurbuz OA (2010) Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int 14(4):425–432

  13. 13.

    Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, Liu J, St Peter WL (2010) Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int 78(6):578–589

  14. 14.

    Block GA, Martin KJ, de Francisco AL (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525

  15. 15.

    Block GA (2003) The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease. Kidney Int 87(Suppl):131–136

  16. 16.

    Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1116

  17. 17.

    Sidhu PS, Desai SR (1997) A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol 70:85–89

  18. 18.

    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215

  19. 19.

    Armstrong D (1998) Free radical and antioxidant protocols. Introduction. Methods Mol Biol 108:5–8

  20. 20.

    Auer T, Khoschsorur GA, Rabl H, Iberer F, Petutschnigg B, Wasler A, Tscheliessnigg KH (1995) Detection of lipid peroxidation products by malondialdehyde (MDA-TBA reaction) in organ transplantation. Transplant Proc 27(5):2749–2751

  21. 21.

    Paglia DE, Valentine WN (1967) Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

  22. 22.

    Rickli EE, Ghazanfar SA, Gibbons BH, Edsall JT (1964) Carbonic anhydrases from human erythrocytes. Preparation and properties of two enzymes. J Biol Chem 239:1065–1078

  23. 23.

    Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126

  24. 24.

    Paragh G, Asztalos L, Seres I (1999) Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 83(2):126–131

  25. 25.

    Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530

  26. 26.

    Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D (2009) Systemic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24(5):1506–1523

  27. 27.

    Stoyanova E, Sandoval SB, Zúñiga LA, El-Yamani N, Coll E, Pastor S, Reyes J, Andres E, Ballarin J, Xamena N, Marcos R (2010) Oxidative DNA damage in chronic renal failure patients. Nephrol Dial Transplant 25(3):879–885

  28. 28.

    Herman M, Ori Y, Chagnac A, Korzets A, Weinstein T, Malachi T, Gafter U (2008) Spontaneous DNA repair increase during hemodialysis. Nephron Clin Pract 108(3):188–193

  29. 29.

    Cangemi R, Angelico F, Loffredo L, Del Ben M, Pignatelli P, Martini A, Violi F (2007) Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 43(5):853–859

  30. 30.

    Engler MM, Engler MB, Malloy MJ (2003) Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: endothelial assessment of risk from lipids in youth (EARLY) trial. Circulation 108(9):1059–1063

  31. 31.

    Selektor Y, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT (2008) Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism. Am J Med Sci 335(2):105–110

  32. 32.

    Andreassi MG (2008) DNA damage, vascular senescence and atherosclerosis. J Mol Med 86:1033–1043

  33. 33.

    Kaya Y, Ari E, Demir H, Soylemez N, Cebi A, Alp H, Bakan E, Gecit I, Asicioglu E, Beytur A (2012) Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage. Nephrol Dial Transplant 27(3):1164–1169

  34. 34.

    Anderson TJ (1999) Assessment and treatment of endothelial dysfunction. J Am Coll Cardiol 34:631–638

  35. 35.

    Van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD (1997) Endothelium- dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 12:14–18

  36. 36.

    Morris ST, McMurray JJ, Rodger RS, Jardine AG (2000) Impaired endothelium dependent vasodilatation in uraemia. Nephrol Dial Transplant 15(8):1194–2000

  37. 37.

    Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G (1995) Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The atherosclerosis risk in communities (ARIC) study. Stroke 26(3):386–391

  38. 38.

    Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 96(5):1432–1437

Download references

Conflict of interest

None declared.

Author information

Correspondence to Elif Ari.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ari, E., Kaya, Y., Demir, H. et al. Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study. Int Urol Nephrol 46, 1843–1849 (2014). https://doi.org/10.1007/s11255-014-0723-0

Download citation


  • Cinacalcet
  • DNA damage
  • Hemodialysis
  • Oxidative stress